Furosemide

Product NDC: 53002-4300
11-digit product format: 530024300
Labeler code: 53002
Product ID: 53002-4300_14a27979-0ea5-4512-83ad-ef575881d869
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Furosemide
Dosage form: TABLET
Route: ORAL
Labeler: RPK Pharmaceuticals, Inc.
Application: ANDA077293
Marketing category: ANDA
Marketing start: 2006-02-01
Marketing end: 0000-00-00
Substance: FUROSEMIDE
Active strength: 40 mg/1
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	53002-4300		I	Inactivated by FDA	2026-08-17
excluded package	package	53002-4300	53002-4300-0	I	Inactivated by FDA	2026-08-17
excluded package	package	53002-4300	53002-4300-3	I	Inactivated by FDA	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 33 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-4300-3	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53002-4300-0	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-4300-3	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53002-4300-0	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-4300-3	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53002-4300-0	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-4300-3	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53002-4300-0	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-4300-3	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53002-4300-0	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-4300-3	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53002-4300-0	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-4300-0	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53002-4300-3	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-4300-0	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53002-4300-3	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-4300-0	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	53002-4300-3	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-4300-0	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	53002-4300-3	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-4300-0	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	53002-4300-3	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A077293-001	FUROSEMIDE	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09
A077293-002	FUROSEMIDE	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09
A077293-003	FUROSEMIDE	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A077293-001	AB
A077293-002	AB
A077293-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077293-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2005-11-09	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077293-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2005-11-09	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077293-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2005-11-09	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A077293-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077293-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077293-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077293-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077293-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077293-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077293-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077293-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077293-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077293-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077293-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077293-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077293-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077293-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077293-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077293-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077293-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077293-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077293-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077293-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077293-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077293-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077293-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077293-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077293-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077293-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077293-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077293-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077293-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077293-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077293-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077293-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077293-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077293-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077293-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077293-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077293-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077293-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077293-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077293-001	AB	1	`1e350fbaab3a…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d80d3aff-3a63-4d7b-a2be-fd9388b04330	Product name	9	20250806
9061e89f-9c86-4196-b34b-886fc1673cc4	Product name	1	20140821

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
53002-4300-0	2025-01-30	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg
53002-4300-3	2025-01-30	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg
53002-4300-0	2023-06-07	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg
53002-4300-3	2023-06-07	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg
53002-4300-0	2023-01-30	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg
53002-4300-3	2023-01-30	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg
53002-4300-0	2020-12-17	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg
53002-4300-3	2020-12-17	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg
53002-4300-0	2020-01-31	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg
53002-4300-3	2020-01-31	FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
53002-4300-0	Furosemide	100 in 1 BOTTLE	TABLET	100		5
53002-4300-3	Furosemide	30 in 1 BOTTLE	TABLET	30		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
53002-4300	FUROSEMIDE (FUROSEMIDE) TABLET [RPK PHARMACEUTICALS, INC.]	5	Legacy NDC, 2 package rows	20230609_865cd360-30af-43b9-a0b9-f90bbc94624f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 30 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Furosemide	FUROSEMIDE	REMEDYREPACK INC.	7cdcd001-ab4b-4210-a455-2e17a7bc4972	2026-07-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	REMEDYREPACK INC.	916de29e-228c-4dfc-bcee-ad9a641316bd	2026-06-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	REMEDYREPACK INC.	571a52ed-5258-46d5-a0d2-9a984cf73895	2026-06-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Unit Dose Solutions, Inc.	54dd664a-c7ec-27f3-e063-6294a90aff9f	2026-06-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Coupler LLC	53e58232-f7f9-c09b-e063-6394a90a5bc4	2026-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Preferred Pharmaceuticals, Inc.	a23fc1e0-2d16-43a8-a34e-f6505dcd6316	2026-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Preferred Pharmaceuticals Inc.	cad102d7-0197-4cff-bb80-9f0b5bcb599b	2026-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Direct_Rx	e9be5c3b-4b18-7ad2-e053-2995a90a4a8b	2026-03-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
FUROSEMIDE	FUROSEMIDE	Northwind Health Company, LLC	1d99e151-75ba-6a75-e063-6294a90a4360	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	QPharma Inc	341e29d9-a6f1-4c77-ae44-9b2c423ea6b4	2025-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	7842eeab-decf-47e7-9134-0add90549a3d	2025-10-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	e20257f6-7cfe-43fa-a672-cc1cb312b83a	2025-10-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Aphena Pharma Solutions - Tennessee, LLC	3f6529fb-1173-ada3-e063-6294a90a76cb	2025-10-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Proficient Rx LP	600ca175-be2b-4c43-b119-133ae21a5601	2025-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Coupler LLC	33ec71e2-8fbd-0703-e063-6294a90a62e1	2025-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	809d9734-12dd-3b1f-e053-2a91aa0aadee	2025-01-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	813c8e9b-61bc-27c4-e053-2a91aa0a9f45	2024-12-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	0dd28e18-2e15-45eb-9a61-a9de7bd7d64e	2024-08-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	809b4f68-4fca-c201-e053-2a91aa0ac18e	2024-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293
Furosemide	FUROSEMIDE	Aphena Pharma Solutions - Tennessee, LLC	307c3b89-f37f-45ee-8ec7-d402008cf2fa	2024-06-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077293 application number: ANDA077293

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313988	furosemide 40 MG Oral Tablet	PSN	865cd360-30af-43b9-a0b9-f90bbc94624f	5
313988	furosemide 40 MG Oral Tablet	SCD	865cd360-30af-43b9-a0b9-f90bbc94624f	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
53002-4300-0	53002430000	100 TABLET in 1 BOTTLE (53002-4300-0)	100 tablet	2017-10-01	0000-00-00	No	No	Current
53002-4300-3	53002430003	30 TABLET in 1 BOTTLE (53002-4300-3)	30 tablet	2017-10-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
FUROSEMIDE TABLETS, USP 20 mg, 40 mg and 80 mg	RPK Pharmaceuticals, Inc.	2023-06-07	HUMAN PRESCRIPTION DRUG LABEL	5